3.34
0.03 (0.91%)
0.03 (0.91%)
Upgrade to Real-Time
Afterhours (Closed)
Low
3.22
High
7.30
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptose Biosciences Inc | APTO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.03 | 0.91% | 3.34 | 17:50:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.35 | 3.285 | 3.37 | 3.34 | 3.31 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.34 | 3.35 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,103 | 1,040,674 | $ 3.32 | $ 3,458,891 | 1,355,579 | 3.22 - 7.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:38:38 | 40 | $ 3.35 | USD |
Aptose Biosciences Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 292.20M | 87.48M | 41.07M | $ - | $ - | -0.84 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Aptose Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.518 | 3.60 | 3.22 | 3.38 | 1,666,835 | -0.178 | -5.06% |
| 1 Month | 5.16 | 5.7827 | 3.22 | 3.98 | 1,840,656 | -1.82 | -35.27% |
| 3 Months | 6.23 | 6.24 | 3.22 | 4.67 | 1,243,499 | -2.89 | -46.39% |
| 6 Months | 4.21 | 7.20 | 3.22 | 5.42 | 2,697,438 | -0.87 | -20.67% |
| 1 Year | 6.93 | 7.30 | 3.22 | 5.39 | 1,948,184 | -3.59 | -51.8% |
| 3 Years | 4.05 | 9.2525 | 1.57 | 5.14 | 999,516 | -0.71 | -17.53% |
| 5 Years | 2.42 | 9.2525 | 0.78 | 4.54 | 744,800 | 0.92 | 38.02% |
Aptose Biosciences Description
| Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. CG026806 (CG-806), its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). |
